Better Buy: Aphria vs. Canopy Growth

It’s been a rough summer and fall for Canadian cannabis stocks. Valuations are at two-year lows. Cannabis companies reported losses and trimmed expansion plans. Then the vaping crisis hit, sending shares tumbling even further. In the markets, sometimes promising investments…

Cannabis Stocks Soar Again Today

Cannabis investors received some exciting news this week. The U.S. House Judiciary Committee — which is charged with overseeing the administration of justice within federal courts and law enforcement agencies — approved a bill on Wednesday that decriminalizes marijuana at…

Canopy Growth: Sell, Buy or Hold?

Last week, Canopy Growth reported Q2 2020 earnings for the period ending September 30, 2019. The company reported an adjusted EBITDA loss of $155.7 million versus $96.1 million that was expected by analysts. However, revenue came in at just $76.6 million…

This Cannabis Stock Gained, While Most Sank Last Week

Cannabis stocks, which have largely been in a downtrend since the spring, had a particularly bad week. Most of the major stocks in the group suffered double-digit percentage losses in a week where the broader market returned nearly 1%. The…